PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 9
- 试验地点
- 2
- 主要终点
- Patient Experience and Preference
研究概览
简要总结
This is a qualitative (interview) study to explore the experiences of people receiving treatment for MM and to understand what matters most to participants when making treatment decisions.
详细描述
People can receive many lines of treatment for multiple myeloma. The investigators would like to understand more about the experiences of people being treated for multiple myeloma including what matters most to participants when considering treatment options, how participants experiences have differed with different treatments and if participants have any treatment preferences. Patients at The Christie who have received five or more lines of treatment for Multiple Myeloma will be eligible to take part in this study. Participants will be asked to take part in an interview which should take approximately 30 minutes to an hour. During the interview, participants will be asked questions regarding their experiences and preference for treatment. Interviews will be conducted either in person or over the phone depending on patient preference. The interviews will be recorded by the research team using a Dictaphone and transcribed by an external transcription service called 1st Class Secretarial. The transcripts of all participant interviews will be reviewed by members of the research team and experiences will be identified and described.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participants with confirmed MM (per standard disease specific diagnostic criteria)
- •Participants must have received ≥ 5 lines of treatment for MM and fit into one of the below treatment categories:
- •Subset 1- Participants must have received an oral anti-cancer therapy and a bi-specific antibody treatment.
- •Subset 2- Participants must have received an oral anti-cancer therapy and if they have not had a bi-specific antibody treatment, they must have received at least one IV therapy.
- •Aged 18 years of age or over
- •Able to provide informed consent
- •Able to communicate in English
排除标准
- •Aged under 18
- •Unable to understand and communicate in the English language
- •Unable to provide written informed consent
结局指标
主要结局
Patient Experience and Preference
时间窗: 30-60 minutes
The interview will explore the experiences of people receiving treatment for multiple myeloma and understand what matters most to them when making treatment decisions.
次要结局
- Treatment and Preference Differences(30-60 minutes)